汇宇制药：西咪替丁注射液获得药品注册证书

Core Viewpoint - Huiyu Pharmaceutical has received the drug registration certificate for its product, Cimetidine Injection, approved by the National Medical Products Administration, indicating a significant regulatory milestone for the company [1] Group 1: Product Approval - The Cimetidine Injection is primarily indicated for the treatment of gastrointestinal ulcers [1] - The original manufacturer, Sumitomo Pharma Co., Ltd., has not yet launched Cimetidine Injection in the domestic market [1] Group 2: Market Competition - Currently, there are 11 companies in China that hold the approval for Cimetidine Injection and have passed or are deemed to have passed the consistency evaluation of generic drug quality and efficacy [1] - Companies that have received approval include Huiyu Pharmaceutical, Jiangsu Lianshui, and Shanxi Nuocheng among others [1]